Home › Funds › Foresite Capital Management IV, LLC › RLAY

Foresite Capital Management IV, LLC position in RLAY

RELAY THERAPEUTICS INC · Health Care

Foresite Capital Management IV, LLC reported holding 1,250,000 shares of RLAY (RELAY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$23.4M, representing 8.06% of its reported portfolio and ranking #4 among its reported holdings. Foresite Capital Management IV, LLC has disclosed RLAY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.25M sh
Reported value held$23.39M
Portfolio Weight8.06%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management IV, LLC's RLAY position evolved

Foresite Capital Management IV, LLC first disclosed a stake in RLAY in Q3 2024 at 1,000,000 shares (US$7.1M). The position peaked in Q2 2026 at 1,250,000 shares, worth US$23.4M. Across 8 filings, Foresite Capital Management IV, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 1,250,000 shares valued at US$23.4M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 25% increase in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.00M $7.08M New
Q4 2024 1.00M $4.12M Hold
Q1 2025 1.00M $2.62M Hold
Q2 2025 1.00M $3.46M Hold
Q3 2025 1.00M $5.22M Hold
Q4 2025 1.00M $8.46M Hold
Q1 2026 1.00M $9.95M Hold
Q2 2026 1.25M $23.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLAY and 13F data

RLAY (RELAY THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLAY

All RLAY fund holders →

FAQ

How long has Foresite Capital Management IV, LLC held RLAY?

Foresite Capital Management IV, LLC has disclosed RLAY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Foresite Capital Management IV, LLC's current position in RLAY?

As of Q2 2026, Foresite Capital Management IV, LLC holds 1.25M shares of RLAY (RELAY THERAPEUTICS INC), valued at $23.39M, representing 8.06% of its reported portfolio and ranking #4.

Has Foresite Capital Management IV, LLC been buying or selling RLAY?

In the latest 13F filing (Q2 2026), Foresite Capital Management IV, LLC increased its position in RLAY. The position peaked in Q2 2026 at 1.25M shares.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.